Chinese expert consensus on the diagnosis and management of prostate cancer in the elderly(2024 edition)
10.3760/cma.j.issn.0254-9026.2025.02.001
- VernacularTitle:老年前列腺癌临床诊治专家共识(2024版)
- Author:
Cheng PANG
1
;
Qiuzi ZHONG
;
Gang ZHU
;
Ming LIU
Author Information
1. 北京医院泌尿外科 国家老年医学中心 中国医学科学院老年医学研究院，北京 100730
- Publication Type:Journal Article
- Keywords:
Prostate;
Therapy;
Prostate cancer;
Expert consensus
- From:
Chinese Journal of Geriatrics
2025;44(2):107-116
- CountryChina
- Language:Chinese
-
Abstract:
The aging demographic in China raises significant concerns, as advanced age has been identified as an independent risk factor for the onset and progression of prostate cancer among the elderly population.Patients with prostate cancer in this age group often exhibit reduced physical functionality and a higher prevalence of comorbidities, leading to notable differences in their diagnosis and treatment compared to younger patients.A comprehensive understanding of the unique characteristics, as well as the clinical diagnostic and treatment protocols for elderly prostate cancer patients, is essential for standardizing and enhancing the quality of care.This consensus, informed by the current state of diagnosis and treatment for elderly prostate cancer patients in China, along with relevant guidelines from both domestic and international sources, outlines methods for assessing the general health status of these patients.It also provides guidance on the management of localized and advanced prostate cancer, in addition to supportive care for elderly patients.The consensus aims to assist healthcare professionals in accurately evaluating the health status of elderly prostate cancer patients and implementing effective interventions and management strategies.
